Cost-Effectiveness Analysis of Amino Acid PET–Guided Surgery for Supratentorial High-Grade Gliomas

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Nuclear Medicine

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2967/jnumed.111.097352PMID 22419752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.

  2011cited by this paper
• Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study

  2011cited by this paper
• [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids].

  2011cited by this paper
• Economic evaluation of new targeted therapies for the first‐line treatment of patients with metastatic renal cell carcinoma

  2011cited by this paper
• Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas

  2011cited by this paper
• Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

  2011cited by this paper
• Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches

  2010cited by this paper
• Cost-Effectiveness of an Intervention to Reduce HIV/STI Incidence and Promote Condom Use among Female Sex Workers in the Mexico–US Border Region

  2010cited by this paper
• Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors.

  2010cited by this paper
• Cost–effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme

  2009cited by this paper
• Management of newly diagnosed glioblastoma: guidelines development, value and application

  2009cited by this paper
• Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].

  2009cited by this paper
• POSITRON EMISSION TOMOGRAPHY‐GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH‐GRADE GLIOMAS: A SURVIVAL ANALYSIS IN 66 CONSECUTIVE PATIENTS

  2009influential reference
• Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  2008cited by this paper
• Cost‐effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme

  2008cited by this paper
• Clinical Applications of PET in Brain Tumors*

  2007cited by this paper
• Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.

  2007cited by this paper
• 11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral Gliomas

  2007cited by this paper
• O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

  2006influential reference
• EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues

  2006cited by this paper
• Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

  2006cited by this paper
• Brain tumors

  2005cited by this paper
• O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

  2005influential reference
• L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.

  2005cited by this paper
• A selected history of expectation bias in physics

  2005cited by this paper
• Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography

  2004cited by this paper
• Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study

  2004cited by this paper
• Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine

  2003cited by this paper
• Debulking or biopsy of malignant glioma in elderly people – a randomised study

  2003cited by this paper
• Reimbursement of the PET in oncology in Europe: a questionnaire based survey

  2003cited by this paper
• Clinical applications of PET

  2002cited by this paper
• Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

  2002cited by this paper
• What Makes Placebo-Controlled Trials Unethical?

  2002cited by this paper
• Correlation Between Postoperative 3-[123I]Iodo-l-α-Methyltyrosine Uptake and Survival in Patients with Gliomas

  2001cited by this paper
• Brain tumors.

  2001cited by this paper
• Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.

  2001cited by this paper
• Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues

  2000cited by this paper
• The cost effectiveness of vaccinating against Lyme disease.

  1999cited by this paper
• Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.

  1998cited by this paper
• Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma

  1997cited by this paper
• The Decision Rules of Cost-Effectiveness Analysis

  1996cited by this paper
• Cost-effectiveness of PET imaging in clinical oncology.

  1996cited by this paper
• Long-term survival in patients with malignant astrocytoma.

  1994cited by this paper
• On the decision rules of cost-effectiveness analysis.

  1993influential reference
• Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.

  1993cited by this paper
• Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference

  1989cited by this paper
• Morbidity and mortality of craniotomy for excision of supratentorial gliomas

  1988cited by this paper
• Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

  1987cited by this paper
• Probabilistic Sensitivity Analysis Using Monte Carlo Simulation

  1985cited by this paper

• Metabolic Heterogeneity in High-Grade Glioma Assessed by Multi-Tracer PET and Ex Vivo Metabolomics: A Systematic Review and Meta-Analysis

  2025cites this paper
• Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PET

  2025cites this paper
• MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis

  2024cites this paper
• Amino Acid PET in Neurooncology

  2023cites this paper
• Hybrid 18F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors

  2023cites this paper
• Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy

  2022cites this paper
• Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy

  2022cites this paper
• A bibliometric and visual analysis of artificial intelligence technologies-enhanced brain MRI research

  2020cites this paper
• State-of-the-art imaging for glioma surgery

  2020cites this paper
• Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses

  2019cites this paper
• Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma.

  2019cites this paper
• PET imaging in patients with brain metastasis-report of the RANO/PET group.

  2019cites this paper
• Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management

  2019cites this paper
• Current status of PET imaging in neuro-oncology

  2019cites this paper
• Paediatric gliomas: diagnosis, molecular biology and management.

  2018cites this paper
• Chapter 12 – Brain Tumors

  2018cites this paper
• Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival

  2018cites this paper
• Chapter 12 Imaging of Brain Tumours

  2018cites this paper
• Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation

  2018cites this paper
• Pseudoprogression after glioma therapy: an update

  2017cites this paper
• PET-CT in the UK: current status and future directions.

  2016cites this paper
• PET-CT in the UK: current status and future

  2016cites this paper
• Imaging of brain tumours

  2015cites this paper
• Applications of PET imaging of neurological tumors with radiolabeled amino acids.

  2015cites this paper
• Cost-effectiveness of PET and PET/computed tomography: a systematic review.

  2015cites this paper
• Thyroid nodules with indeterminate cytology: molecular imaging with 99mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma® gene expression classifier

  2014cites this paper
• Clinical Impact of Amino Acid PET in Gliomas

  2014cites this paper
• 18F-Fluorodeoxyglucose PET Procedures: Health Economic Aspects in Neurology

  2014cites this paper
• O-(2-[18F]fluoroethyl)-l-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy

  2014cites this paper
• Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review.

  2014cites this paper
• PET Imaging of Brain Tumors

  2013cites this paper
• Novel Quantitative Techniques in Hybrid (PET-MR) Imaging of Brain Tumors.

  2013cites this paper
• FET PET in Neuro-oncology and in Evaluation of Treatment Response.

  2013cites this paper
• Hybrid imaging worldwide-challenges and opportunities for the developing world: a report of a Technical Meeting organized by IAEA.

  2013cites this paper
• Cost-effectiveness of 99mTc-MIBI in the evaluation of thyroid nodules for malignancy: a new lease of life for an old radiopharmaceutical?

  2013cites this paper
• Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.

  2013cites this paper
• The Use of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis

  2013cites this paper
• Diagnostic accuracy of F-18-fluoroethyltyrosine PET and PET/CT in patients with brain tumor

  2013cites this paper
• Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis

  2013cites this paper
• Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas

  2012cites this paper